Localisation of breast cancer resistance protein in microvessel endothelium of human brain

NeuroReport

Volumn 13, Issue 16, 2002, Pages 2059-2063

  Cooray, Hiran C ^a   Blackmore, Colin G ^a   Maskell, Lynn ^a,b   Barrand, Margery A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

ABC transporters; BCRP; Blood brain barrier; Brain tumours; Endothelium; Human; MRP; Multidrug resistance; P gp

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; COMPLEMENTARY DNA; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN TUMOR; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOMA; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MENINGIOMA; MICROVASCULATURE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MICROCIRCULATION; MICROSCOPY, CONFOCAL; MONOSACCHARIDE TRANSPORT PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0037113346     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200211150-00014     Document Type: Article

References (24)

1. Schinkel AH. Adv Drug Deliv Rev 36, 179-194 (1999).
2. Wijnholds J, deLange EC, Scheffer GL et al. J Clin Inves 105, 279-285 (2000).
3. Rao VV, Dahlheimer JL, Bardgett ME et al. Proc Natl Acad Sci USA 96, 3900-3905 (1999).
4. Huai-Yun H, Secrest DT, Mark KS et al. Biochem Biophys Res Commun 243, 816-820 (1998).
5. Zhang Y, Han H, Elmquist WF et al. Brain Res 876, 148-153 (2000).
6. Fricker G, Nobmann S and Miller DS. Br J Pharmacol 135, 1308-1314 (2002).
7. Scheffer GL, Kool M, Heijn M et al. Cancer Res 60, 5267-5269 (2000).
8. Regina A, Koman A, Piciotti M et al. J Neurochem 71, 705-715 (1998).
9. Flens MJ, Zaman GJ, van der Valk P et al. Am J Pathol 148, 1237-1247 (1996).
10. Seetharaman S, Barrand MA, Maskell L et al. J Neurochem 70, 1151-1159 (1998).
11. Sisodiya SM, Lin WR, Harding BN et al. Brain 125, 22-31 (2002).
12. Bredel M. Brain Res Brain Res Rev 35, 161-204 (2001).
13. Litman T, Brangi M, Hudson E et al. J Cell Sci 113, 2011-2021 (2000).
14. Scheffer GL, Maliepaard M, Pijnenborg AC et al. Cancer Res 60, 2589-2593 (2000).
15. Allikmets R, Schriml LM, Hutchinson A et al. Cancer Res 58, 5337-5339 (1998).
16. Maliepaard M, Scheffer GL, Faneyte IF et al. Cancer Res 61, 3458-3464 (2001).
17. Eisenblatter T and Galla HJ. Biochem Biophys Res Commun 293, 1273-1278 (2002).
18. Kool M, de Haas M, Scheffer GL et al. Cancer Res 57, 3537-3547 (1997).
19. Gerhart DZ, LeVasseur RJ, Broderius MA et al. J Neurosci Res 22, 464-472 (1989).
20. Decleves X, Fajac A, Lehmann-Che J et al. Int J Cancer 98, 173-180 (2002).
21. Demeule M, Shedid D, Baeulieu E et al. Int J Cancer 93, 62-66 (2001).
22. Matsumoto T, Tani E, Kaba K et al. J Neurosurgery 74, 460-466 (1998).
23. Yokogami K, Kawano H, Moriyama T et al. Eur J Nucl Med 25, 401-409 (1998).
24. Golden PL and Pardridge WM. Cell Mol Neurobiol 20, 165-181 (2000).